Skip to main content

Navigation group

Type at least 3 characters
2,250 articles

Articles

Original Research

Published on 13 Dec 2023

Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety

in Neuropharmacology

  • M. T. Corasaniti
  • G. W. Lawrence
  • G. Bagetta
  • R. Iannacchero
  • A. Tarsitano
  • A. Monteleone
  • M. Pagliaro
  • P. Tonin
  • G. Sandrini
  • P. Nicotera
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1296577
  • 3,109 views
  • 1 citation

Original Research

Published on 28 Nov 2023

Lippia origanoides essential oil possesses anticonvulsant effect in pentylenetetrazol-induced seizures in rats: a behavioral, electroencephalographic, and electromyographic study

in Neuropharmacology

  • Daniella Bastos de Araújo
  • Anthony Lucas Gurgel do Amaral
  • Suzane Maia da Fonseca
  • Keyla Rodrigues de Souza
  • Allane Patrícia Santos da Paz
  • Vanessa Jóia de Mello
  • Gabriela Brito Barbosa
  • Maria Klara Otake Hamoy
  • Moisés Hamoy
Lippia origanoides essential oil possesses anticonvulsant effect in pentylenetetrazol-induced seizures in rats: a behavioral, electroencephalographic, and electromyographic study
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1289336
  • 1,648 views
  • 3 citations